Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Other Non-Current Assets (2020 - 2025)

Silo Pharma (SILO) has disclosed Other Non-Current Assets for 6 consecutive years, with $56226.0 as the latest value for Q2 2025.

  • Quarterly Other Non-Current Assets fell 9.41% to $56226.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $56226.0 through Jun 2025, down 9.41% year-over-year, with the annual reading at $59145.0 for FY2024, 8.98% down from the prior year.
  • Other Non-Current Assets hit $56226.0 in Q2 2025 for Silo Pharma, up from $48125.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $72285.0 in Q3 2022 to a low of $19375.0 in Q1 2021.
  • Historically, Other Non-Current Assets has averaged $53668.4 across 5 years, with a median of $60302.0 in 2021.
  • Biggest five-year swings in Other Non-Current Assets: soared 165.66% in 2022 and later fell 24.24% in 2025.
  • Year by year, Other Non-Current Assets stood at $26659.0 in 2021, then skyrocketed by 165.66% to $70821.0 in 2022, then dropped by 8.24% to $64983.0 in 2023, then fell by 8.98% to $59145.0 in 2024, then dropped by 4.94% to $56226.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for SILO at $56226.0 in Q2 2025, $48125.0 in Q1 2025, and $59145.0 in Q4 2024.